Nearly one-half of Americans said they would be willing to spend up to $100 a month for new weight loss medicines such as semaglutide (Wegovy—Novo Nordisk), and one-third said they would indefinitely pay whatever they can afford to get the drugs, according to a new survey by STAT and Harris Poll.

The prevalence of diabetes is expected to more than double by 2050, according to a new Lancetstudy. Approximately 1 in 10 people worldwide at that time will have diabetes, marking a 60% increase in the prevalence of the disease, said the study findings.

Sales of e-cigarettes increased by almost 50% from 2020 to 2022, according to a report published in CDC’s Morbidity and Mortality Weekly Report. The report also found that after January 2020, sales of mint- and other-flavored prefilled cartridges died down, and disposable e-cigarettes in fruit, sweet, and other flavors increased. Disposable e-cigarettes in youth-appealing flavors are now more commonly sold than prefilled units.

Members of CDC’s Advisory Committee on Immunization Practices (ACIP) recommended new respiratory syncytial virus (RSV) vaccines for older adults, but stopped short of saying all older adults should receive them.

A new report from CDC indicates that millions of U.S. adults are not taking their medications as prescribed due to costs.